1. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53(5): 812-8. [
DOI:10.1161/HYPERTENSIONAHA.108.127977] [
PMID]
2. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet. Gynecol 2003;102(1): 181-192. [
DOI:10.1016/S0029-7844(03)00475-7]
3. Moore KL, Persaud T. The Developing Human: Clinically Oriented Embryology [slides]: Saunders; 1993. [
URL]
4. Ammon Avalos L, Galindo C, Li DK. A systematic review to calculate background miscarriage rates using life table analysis. Birth Defects Research Part A: Clin Mol Teratol 2012;94(6): 417-23. [
DOI:10.1002/bdra.23014] [
PMID]
5. Martin Jr JN, Owens MY, Keiser SD, Parrish MR, Tam Tam KB, Brewer JM, et al. Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hypertens Pregnancy. 2012;31(1): 79-90. [
DOI:10.3109/10641955.2010.525277] [
PMID]
6. Conde-Agudelo A, Romero R, Roberts JM. Tests to predict preeclampsia. Chesley's hypertensive disorders in pregnancy: Elsevier; 2015. p. 221-251. [
DOI:10.1016/B978-0-12-407866-6.00011-0]
7. Gallo DM, Wright D, Casanova C, Campanero M, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation. Am J Obstet Gynecol 2016;214(5): 619. [
DOI:10.1016/j.ajog.2015.11.016] [
PMID]
8. Cook CM, Ellwood D. A longitudinal study of the cervix in pregnancy using transvaginal ultrasound. BJOG: Br J Obstet Gynaecol 1996;103(1): 16-8. [
DOI:10.1111/j.1471-0528.1996.tb09509.x] [
PMID]
9. Andrews WW, Sibai BM, Thom EA, Dudley D, Ernest J, McNellis D, et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet. Gynecol 2003;101(5): 847-55. [
DOI:10.1097/00006250-200305000-00005] [
PMID]
10. Unterscheider J, O'Donoghue K, Malone FD. Guidelines on fetal growth restriction: a comparison of recent national publications. Am. J. Perinatol 2015;32(04): 307-716. [
DOI:10.1055/s-0034-1387927] [
PMID]
11. De Jesus LC, Pappas A, Shankaran S, Li L, Das A, Bell EF, et al. Outcomes of small for gestational age infants born at< 27 weeks' gestation. J Pediatr 2013;163(1): 55-60. [
DOI:10.1016/j.jpeds.2012.12.097] [
PMID] [
PMCID]
12. Briand V, Saal J, Ghafari C, Huynh B-T, Fievet N, Schmiegelow C, et al. Fetal growth restriction is associated with malaria in pregnancy: a prospective longitudinal study in Benin. J Infect Dis 2016; 214(3): 25-417. [
DOI:10.1093/infdis/jiw158] [
PMID]
13. Fialova L, Malbohan I. Pregnancy-associated plasma protein A (PAPP-A): theoretical and clinical aspects. Bratislavske lek listy 2002;103(6): 194-205. [
Google Scholar]
14. McIntyre J, Hsi B, Faulk WP, Klopper A, Thomson R. Immunological studies of the human placenta: functional and morphological analysis of pregnancy-associated plasma protein A (PAPP-A). Immunology 1981;44(3): 577. [
PMID] [
PMCID]
15. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A 1999;96(6): 3149-3153. [
DOI:10.1073/pnas.96.6.3149] [
PMID] [
PMCID]
16. Irwin J, Suen L-F, Martina N, Mark S, Giudice L. Role of the IGF system in trophoblast invasion and pre-eclampsia.Hum Reprod 1999;14(suppl_2): 90-98. [
DOI:10.1093/humrep/14.suppl_2.90] [
PMID]
17. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002;87(4): 1762-1767. [
DOI:10.1210/jcem.87.4.8430] [
PMID]
18. Quattrocchi T, Baviera G, Pochiero T, Basile F, Rizzo L, Santamaria A, et al. Maternal serum PAPP-A as an early marker of obstetric complications? Fetal Diagn Ther 2015;37(1): 33-36. [
DOI:10.1159/000365147] [
PMID]
19. R Katie Morris, Ashwini Bilagi, Pooja Devani , Mark D Kilby. Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis. Prenat Diagn 2017 Mar;37(3): 253-265. [
DOI:10.1002/pd.5001] [
PMID]
20. Maryam Sadat Hoseini , Samaneh Sheibani , Mehrdad Sheikhvatan. The evaluating of pregnancy-associated plasma protein-A with the likelihood of small for gestational age. Obstet Gynecol Sci 2020 May;63(3): 225-230. [
DOI:10.5468/ogs.2020.63.3.225] [
PMID] [
PMCID]
21. Roman V Kapustin, Tatyana K Kascheeva , Elena N Alekseenkova , Elizaveta V Shelaeva. Are the first-trimester levels of PAPP-A and fb-hCG predictors for obstetrical complications in diabetic pregnancy?. J Matern Fetal Neonatal Med 2020 Mar 30;1-7. [
Google Scholar]
22. Biyuan He, Chunhong Hu, Yuqing Zhou. First-trimester screening for fetal growth restriction using Doppler color flow analysis of the uterine artery and serum PAPP-A levels in unselected pregnancies. J Matern Fetal Neonatal Med 2021 Dec;34(23): 3857-3861. [
DOI:10.1080/14767058.2019.1701646] [
PMID]
23. Ning Yu , Hongyan Cui, Xu Chen , Ying Chang. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction. Taiwan J Obstet Gynecol 2017 Jun;56(3): 358-361. [
DOI:10.1016/j.tjog.2017.01.009] [
PMID]
24. Ximena Carolina Romero Infante , Montserrat Uriel, Alexandra Porras Ramírez , Sara Rincón Franco. Comparison of preeclampsia and fetal growth restriction screenings at first trimester in a high-risk population. J Obstet Gynaecol Res 2021 Feb;47(2): 765-773. [
DOI:10.1111/jog.14605] [
PMID]
25. Zeba Khanam, Pratima Mittal, Jyotsna Suri. Does the Addition of Serum PAPP-A and β-hCG Improve the Predictive Value of Uterine Artery Pulsatility Index for Preeclampsia at 11-14 Weeks of Gestation? A Prospective Observational Study. J Obstet Gynaecol India 2021 Jun;71(3): 226-234. [
DOI:10.1007/s13224-020-01420-7] [
PMID] [
PMCID]
26. X-W Sun, X-H Li, C Zhang, F-Q Meng, Y-G Xing, Y Ding. Correlation analysis of serum placental growth factor, pregnancy-related plasma protein-A and disease severity in patients with hypertensive disorder in pregnancy. Eur Rev Med Pharmacol Sci 2021 Feb;25(4): 1788-1795. [
Google Scholar]
27. L Noël , G P Guy, S Jones, K Forenc, E Buck , A T Papageorghiou, et al. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?. Ultrasound Obstet Gynecol 2021 Oct;58(4): 540-545. [
DOI:10.1002/uog.23669] [
PMID]